WARREN WHITEHEAD is listed as an executive officer and director on 12 SEC Form D filings by 3 issuers between Mar 2013 and May 2023: Satellos Bioscience Inc. (Toronto, Ontario, Canada (as filed: A6) — biotechnology — 2022–2023; $33.3M reported sold to 16 investors), LORUS THERAPEUTICS INC (Toronto, Ontario, Canada (as filed: A6) — biotechnology — 2014; $28.3M reported sold to 3 investors) and ProMIS Neurosciences Inc. (Toronto, Ontario, Canada (as filed: A6) — biotechnology — 2013–2015; $18.1M reported sold to 34 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 10 years. Across those companies the filings report $79.6M sold in total.
Listed alongside NEIL CASHMAN (9 shared filings), ROBERT GUNDEL (7 shared filings), AZIZ MEKOUAR (6 shared filings), HANS BLACK (6 shared filings), JOHANNES MINHO ROTH (6 shared filings) and 26 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around WARREN. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 7 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 12 public filings for WARREN WHITEHEAD and found 8 differences, 1 worth asking the sponsor about: Paid seller listed without a CRD number: RBC Dominion Securities Inc; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.